Takeda, NY Academy of Sciences establish $200k research prize; CapsoVision receives FDA clearance for CapsoCam Plus & more: 5 GI company key notes

Here are five updates on gastroenterology and endoscopy companies.

Advertisement

Osaka, Japan-based Takeda Pharmaceutical and the New York Academy of Sciences established the Takeda Innovators in Science Award.

Saratoga, Calif.-based CapsoVision earned FDA 510(k) clearance for its small bowel capsule endoscope system, CapsoCam Plus.

As Rancho Santa Margarita, Calif-based Integrated Endoscopy prepares for the early 2017 launch of its single-use arthroscope, the company appointed several new members to its corporate leadership team.

New York-based Intercept Pharmaceuticals released data from three studies related to the Phase 3 POISE trial of Ocaliva.

New Haven, Conn.-based Alexion Pharmaceuticals has released data from studies related to the Phase 3 ARISE trial of Kanuma

More articles on gastroenterology and endoscopy:
50% of patients treated with Kanuma experience reduced liver fibrosis: 3 study insights
Takeda Pharmaceutical, New York Academy of Sciences establish $200k research prize: 3 notes
AGA, NACCME develop 3 regional educational programs about IBD: 3 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.